GERD/PUD Flashcards
List a few Paxton lifestyle interventions for GERD.
- do not lie down for at least 2hr after eating/drinking
- elevate head of bed
- weight loss
- routine avoidance of foods that have been thought to trigger reflux (chocolate, caffeine, alcohol, spicy) is no longer recommended **
Describe the general pharm management of GERD (based on severity)
Mild, infrequent: antacid or H2RA PRN
Inadequate control or severe, frequent sxs: PPI qd x 8wk
Continued sxs: BID PPI or switch to different PPI
Nocturnal sxs despite BID PPI: add H2RA
What are the 3 main salts used as antacids?
- Al (OH)3 - aluminum hydroxide
- CaCO3 - calcium carbonate
- Mg (OH)3 - magnesium hydroxide
What is the MOA of antacids? Clinical use?
MOA:
- neutralize gastric acidity by increasing pH
- inhibit proteolytic activity of pepsin when gastric pH > 4
Clinical indication: dyspepsia, GERD prn
What are two different drug interactions related to antacids?
- DEC TTC/FQ absorption (cations)
2. DEC absorption d/t “alkalization” of stomach - Fe***
also - ketoconazole, digoxin, phenytoin
List the three ADRs associated with Al(OH)3.
- hypophosphatemia
- aluminum intoxication (encephalopathy, seizure, coma in CKD pt)
- constipation**
List the two ADRs associated with CaCO3.
- Constipation**
- Milk-alkali syndrome (HA, Nausea, irritability, weakness, hypercalcemia, metabolic alkalosis, hypophosphatemia)
What are two ADRs associated with Mg(OH)2.
- hyperMg
- laxative effects **
Reiteration - which two antacids cause constipation? Which causes laxative effects?
Constipation: aluminum hydroxide, calcium carbonate
Laxative: magnesium hydroxide
What is the MOA of Sucralfate (Carafate) and clinical indications?
Aluminum hydroxide complex of sucrose
MOA: forms a “protective coating” by binding with positively charged proteins in exudates
Indications:
- GERD/PUD
- Tx NSAID-induced mucosal damage
- prevent stress ulcer
** suspension - topical tx of stomatitis d/t chemo **
What drug interaction should you be aware of with sucralfate? What are two ADRs?
Interaction: DEC absorption of digoxin, phenytoin, warfarin, ketoconazole, theophylline, TTC, FQ
ADRs: constipation, aluminum tox in CKD pt
Name two first gen and two second gen H2RAs.
First gen: cimetidine & ranitidine*
Second gen: famotidine* & nizatidine
Why was ranitidine pulled off the shelves?
Concern for NDMA in the drug
Currently being investigated by the FDA
Describe the MOA of H2RAs.
- inhibit gastric secretion by blocking H2
- reduces basal acid secretion primarily (some food stimulated secretion)
- good for PRN use
- less potent at reducing nocturnal secretion
What are the clinical indications of H2RAs?
- dyspepsia / GERD / PUD
- SUP in critically ill pt [may lead to more pneumonia and CDI**]
- gastric hypersecretory states (ZES, MEN) but PPIs often more effective